These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 7237446)

  • 41. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
    Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
    Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK.
    Lassiani L; de Nardo MM; Nisi C; Varnavas A
    Farmaco Sci; 1988 Mar; 43(3):227-38. PubMed ID: 3417008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML; Redmond HP; Bouchier-Hayes DJ
    J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Ceschia V; Pacor S; Zabucchi G
    Anticancer Res; 1991; 11(3):1109-13. PubMed ID: 1888145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis carcinoma treated with proteinase inhibitors.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1984; 4(4-5):221-4. PubMed ID: 6435503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice.
    Carmel RJ; Brown JM
    Cancer Res; 1977 Jan; 37(1):145-51. PubMed ID: 137074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary metastases of the lewis lung tumor-cell kinetics and response to cyclophosphamide at different sizes.
    Hill RP; Stanley JA
    Cancer Treat Rep; 1977; 61(1):29-36. PubMed ID: 861961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
    Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
    Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reductive effect of lonazolac on lung metastasis formation in mice.
    Mamytbeková A; Hájícek J; Grimová J; Rezábek K
    Neoplasma; 1990; 37(3):349-55. PubMed ID: 2370919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimetastatic action of a new analog of dacarbazine in mice bearing Lewis lung carcinoma.
    Perissin L; Facchin P; Bedini A; Diamantini G; Tontini A; Tarzia G
    Anticancer Res; 2000; 20(3A):1513-7. PubMed ID: 10928064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.
    Isoai A; Goto-Tsukamoto H; Yamori T; Oh-hara T; Tsuruo T; Silletti S; Raz A; Watanabe H; Akedo H; Kumagai H
    Cancer Res; 1994 Mar; 54(5):1264-70. PubMed ID: 8118815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
    Borgström P; Torres Filho IP; Hartley-Asp B
    Anticancer Res; 1995; 15(3):719-28. PubMed ID: 7544090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
    Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
    Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors.
    Abdallah RM; Starkey JR; Meadows GG
    J Natl Cancer Inst; 1987 Apr; 78(4):759-69. PubMed ID: 3470551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival of mice with metastatic osteosarcoma treated by cyclophosphamide or radiotherapy.
    Shaeffer J; El-Mahdi AM; Constable WC
    Cancer Res; 1975 Dec; 35(12):3596-8. PubMed ID: 1059504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs.
    Strzadała L; Rak J; Kuśnierczyk H
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):831-6. PubMed ID: 3914253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of platelet aggregating inhibitor on pulmonary metastases of tumor cells after surgical resection].
    Yano S
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):654-63. PubMed ID: 8225173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.